Skip to main content
Log in

Aberrant microRNA expression and its implications in the pathogenesis of leukemias

  • Review
  • Published:
Cellular Oncology Aims and scope Submit manuscript

Abstract

Background

MicroRNAs (miRNAs) are a class of non-coding, endogenous, small RNAs that negatively regulate gene expression by inducing degradation or translational inhibition of target mRNAs. Aberrant expression of miRNAs appears to be a common characteristic of hematological malignancies including leukemias.

Aim

Here we review the available data supporting a role of aberrant expression of miRNAs in the pathogenesis of leukemias including acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myeloid leukemia (CML), and chronic lymphocytic leukemia (CLL).

Conclusions

The expression signatures of miRNAs provide exciting opportunities in the diagnosis, prognosis, and therapy of leukemia. Since miRNAs can function as either oncogenes or tumor suppressor genes in leukemogenesis, the potential of using these small RNAs as therapeutic targets opens up new opportunities for leukemia therapy by either inhibiting or augmenting their activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Abbreviations

MiRNAs:

MicroRNAs

AML:

Acute myeloid leukemia

CN-AML:

Cytogenetically normal acute myeloid leukemia

ALL:

Acute lymphoblastic leukemia

CLL:

Chronic lymphocytic leukemia

CML:

Chronic myeloid leukemia

Ph:

Philadelphia chromosome

BM:

Bone marrow

USF2:

Upstream transcription factor 2

BCL-2:

B-cell leukemia/lymphoma-2

E2F-1:

E2 transcription factor family-1

TCL-1:

T-cell leukemia/lymphoma1

MCL-1:

Myeloid cell leukemia 1

Itch:

Itchy E3 ubiquitin protein ligase homolog

C/EBPα:

CCAAT/enhancer binding protein alpha

PLK2:

Polo-like kinase 2

AE:

AML1/ETO

FLT3-ITD:

Internal tandem duplication of FMS-like tyrosine kinase 3

HOX:

Homeobox

MEIS1:

Myeloid ecotropic viral integration site 1

c-Kit:

v-Kit hardy-zuckerman 4 feline sarcoma viral oncogene homolog

CNS:

Central nervous system

MDR:

Minimally-deleted region

DLEU:

Deleted in leukemia

DLBCL:

Diffuse large B-cell lymphoma

MBL:

Monoclonal B-cell lymphocytosis

IgVH :

Immunoglobulin heavy-chain variable-region

ZAP-70:

70-kDa zeta-associated protein

LPL:

Lipoprotein lipase

qRT-PCR:

Quantitative real-time polymerase chain reaction

OS:

Overall survival

TFS:

Treatment-free survival

OG:

Oncogene

TS:

Tumor suppressor

References

  1. X. Liu, K. Fortin, Z. Mourelatos, MicroRNAs: biogenesis and molecular functions. Brain Pathol 18, 113–121 (2008)

    Article  PubMed  CAS  Google Scholar 

  2. S. Babashah, M. Soleimani, The oncogenic and tumour suppressive roles of microRNAs in cancer and apoptosis. Eur. J. Cancer 47, 1127–1137 (2011)

    Article  PubMed  CAS  Google Scholar 

  3. R.C. Lee, R.L. Feinbaum, V. Ambros, The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75, 843–854 (1993)

    Article  PubMed  CAS  Google Scholar 

  4. B.J. Reinhart, F.J. Slack, M. Basson, A.E. Pasquinelli, J.C. Bettinger, A.E. Rougvie, H.R. Horvitz, G. Ruvkun, The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403, 901–906 (2000)

    Article  PubMed  CAS  Google Scholar 

  5. M.J. Bueno, I. Perez de Castro, M. Malumbres, Control of cell proliferation pathways by microRNAs. Cell Cycle 7, 3143–3148 (2008)

    Article  PubMed  CAS  Google Scholar 

  6. Y. Lee, M. Kim, J. Han, K.H. Yeom, S. Lee, S.H. Baek, V.N. Kim, MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 23, 4051–4060 (2004)

    Article  PubMed  CAS  Google Scholar 

  7. G.M. Borchert, W. Lanier, B.L. Davidson, RNA polymerase III transcribes human microRNAs. Nat. Struct. Mol. Biol. 13, 1097–1101 (2006)

    Article  PubMed  CAS  Google Scholar 

  8. Y. Lee, K. Jeon, J.T. Lee, S. Kim, V.N. Kim, MicroRNA maturation: stepwise processing and subcellular localization. EMBO J. 21, 4663–4670 (2002)

    Article  PubMed  CAS  Google Scholar 

  9. G. Hutvagner, P.D. Zamore, A microRNA in a multiple-turnover RNAi enzyme complex. Science 297, 2056–2060 (2002)

    Article  PubMed  CAS  Google Scholar 

  10. R. Garzon, G.A. Calin, C.M. Croce, MicroRNAs in Cancer. Annu Rev Med 60, 167–179 (2009)

    Article  PubMed  CAS  Google Scholar 

  11. M. Garofalo, C.M. Croce, microRNAs: Master regulators as potential therapeutics in cancer. Annu. Rev. Pharmacol. Toxicol. 51, 25–43 (2011)

    Article  PubMed  CAS  Google Scholar 

  12. O.A. Kent, J.T. Mendell, A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene 25, 6188–6196 (2006)

    Article  PubMed  CAS  Google Scholar 

  13. L. Ma, R.A. Weinberg, MicroRNAs in malignant progression. Cell Cycle 7, 570–572 (2008)

    Article  PubMed  CAS  Google Scholar 

  14. A. Esquela-Kerscher, F.J. Slack, Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer 6, 259–269 (2006)

    Article  PubMed  CAS  Google Scholar 

  15. G.A. Calin, C.M. Croce, MicroRNA signatures in human cancers. Nat. Rev. Cancer 6, 857–866 (2006)

    Article  PubMed  CAS  Google Scholar 

  16. M. Fabbri, R. Garzon, M. Andreeff, H.M. Kantarjian, G. Garcia-Manero, G.A. Calin, MicroRNAs and noncoding RNAs in hematological malignancies: molecular, clinical and therapeutic implications. Leukemia 22, 1095–1105 (2008)

    Article  PubMed  CAS  Google Scholar 

  17. S. Yendamuri, G.A. Calin, The role of microRNA in human leukemia: a review. Leukemia 23, 1257–1263 (2009)

    Article  PubMed  CAS  Google Scholar 

  18. J. Kluiver, B.J. Kroesen, S. Poppema, A. van den Berg, The role of microRNAs in normal hematopoiesis and hematopoietic malignancies. Leukemia 20, 1931–1936 (2006)

    Article  PubMed  CAS  Google Scholar 

  19. R. Garzon, C.M. Croce, MicroRNAs in normal and malignant hematopoiesis. Curr. Opin. Hematol. 15, 352–358 (2008)

    Article  PubMed  CAS  Google Scholar 

  20. Z. Li, J. Lu, M. Sun, S. Mi, H. Zhang, R.T. Luo, P. Chen, Y. Wang, M. Yan, Z. Qian, M.B. Neilly, J. Jin, Y. Zhang, S.K. Bohlander, D.E. Zhang, R.A. Larson, M.M. Le Beau, M.J. Thirman, T.R. Golub, J.D. Rowley, J. Chen, Distinct microRNA expression profiles in acute myeloid leukemia with common translocations. Proc. Natl. Acad. Sci. U. S. A. 105, 15535–15540 (2008)

    Article  PubMed  CAS  Google Scholar 

  21. H. Seca, G.M. Almeida, J.E. Guimaraes, M.H. Vasconcelos, miR signatures and the role of miRs in acute myeloid leukaemia. Eur. J. Cancer 46, 1520–1527 (2010)

    Article  PubMed  CAS  Google Scholar 

  22. H. Zhao, D. Wang, W. Du, D. Gu, R. Yang, MicroRNA and leukemia: tiny molecule, great function. Crit Rev Oncol Hematol 74, 149–155 (2010)

    Article  PubMed  Google Scholar 

  23. A. Dixon-McIver, P. East, C.A. Mein, J.B. Cazier, G. Molloy, T. Chaplin, T. Andrew Lister, B.D. Young, S. Debernardi, Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia. PLoS One 3, e2141 (2008)

    Article  PubMed  CAS  Google Scholar 

  24. M. Jongen-Lavrencic, S.M. Sun, M.K. Dijkstra, P.J. Valk, B. Lowenberg, MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia. Blood 111, 5078–5085 (2008)

    Article  PubMed  CAS  Google Scholar 

  25. C. Nervi, F. Fazi, F. Grignani, Oncoproteins, heterochromatin silencing and microRNAs: a new link for leukemogenesis. Epigenetics 3, 1–4 (2008)

    Article  PubMed  Google Scholar 

  26. F. Fazi, A. Rosa, A. Fatica, V. Gelmetti, M.L. De Marchis, C. Nervi, I. Bozzoni, A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell 123, 819–831 (2005)

    Article  PubMed  CAS  Google Scholar 

  27. F. Fazi, S. Racanicchi, G. Zardo, L.M. Starnes, M. Mancini, L. Travaglini, D. Diverio, E. Ammatuna, G. Cimino, F. Lo-Coco, F. Grignani, C. Nervi, Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein. Cancer Cell 12, 457–466 (2007)

    Article  PubMed  CAS  Google Scholar 

  28. J.B. Johnnidis, M.H. Harris, R.T. Wheeler, S. Stehling-Sun, M.H. Lam, O. Kirak, T.R. Brummelkamp, M.D. Fleming, F.D. Camargo, Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 451, 1125–1129 (2008)

    Article  PubMed  CAS  Google Scholar 

  29. F. Rosenbauer, S. Koschmieder, U. Steidl, D.G. Tenen, Effect of transcription-factor concentrations on leukemic stem cells. Blood 106, 1519–1524 (2005)

    Article  PubMed  CAS  Google Scholar 

  30. M. Bousquet, C. Quelen, R. Rosati, V. Mansat-De Mas, R. La Starza, C. Bastard, E. Lippert, P. Talmant, M. Lafage-Pochitaloff, D. Leroux, C. Gervais, F. Viguie, J.L. Lai, C. Terre, B. Beverlo, C. Sambani, A. Hagemeijer, P. Marynen, G. Delsol, N. Dastugue, C. Mecucci, P. Brousset, Myeloid cell differentiation arrest by miR-125b-1 in myelodysplastic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation. J Exp Med 205, 2499–2506 (2008)

    Article  PubMed  CAS  Google Scholar 

  31. L. Fontana, E. Pelosi, P. Greco, S. Racanicchi, U. Testa, F. Liuzzi, C.M. Croce, E. Brunetti, F. Grignani, C. Peschle, MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation. Nat Cell Biol 9, 775–787 (2007)

    Article  PubMed  CAS  Google Scholar 

  32. S. Mi, Z. Li, P. Chen, C. He, D. Cao, A. Elkahloun, J. Lu, L.A. Pelloso, M. Wunderlich, H. Huang, R.T. Luo, M. Sun, M. He, M.B. Neilly, N.J. Zeleznik-Le, M.J. Thirman, J.C. Mulloy, P.P. Liu, J.D. Rowley, J. Chen, Aberrant overexpression and function of the miR-17-92 cluster in MLL-rearranged acute leukemia. Proc. Natl. Acad. Sci. U. S. A. 107, 3710–3715 (2010)

    Article  PubMed  CAS  Google Scholar 

  33. P. Wong, M. Iwasaki, T.C. Somervaille, F. Ficara, C. Carico, C. Arnold, C.Z. Chen, M.L. Cleary, The miR-17-92 microRNA polycistron regulates MLL leukemia stem cell potential by modulating p21 expression. Cancer Res. 70, 3833–3842 (2010)

    Article  PubMed  CAS  Google Scholar 

  34. R. Garzon, S. Volinia, C.G. Liu, C. Fernandez-Cymering, T. Palumbo, F. Pichiorri, M. Fabbri, K. Coombes, H. Alder, T. Nakamura, N. Flomenberg, G. Marcucci, G.A. Calin, S.M. Kornblau, H. Kantarjian, C.D. Bloomfield, M. Andreeff, C.M. Croce, MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood 111, 3183–3189 (2008)

    Article  PubMed  CAS  Google Scholar 

  35. R. Popovic, L.E. Riesbeck, C.S. Velu, A. Chaubey, J. Zhang, N.J. Achille, F.E. Erfurth, K. Eaton, J. Lu, H.L. Grimes, J. Chen, J.D. Rowley, N.J. Zeleznik-Le, Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization. Blood 113, 3314–3322 (2009)

    Article  PubMed  CAS  Google Scholar 

  36. G. Marcucci, K. Maharry, M.D. Radmacher, K. Mrozek, T. Vukosavljevic, P. Paschka, S.P. Whitman, C. Langer, C.D. Baldus, C.G. Liu, A.S. Ruppert, B.L. Powell, A.J. Carroll, M.A. Caligiuri, J.E. Kolitz, R.A. Larson, C.D. Bloomfield, Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study. J. Clin. Oncol. 26, 5078–5087 (2008)

    Article  PubMed  CAS  Google Scholar 

  37. M.L. Choong, H.H. Yang, I. McNiece, MicroRNA expression profiling during human cord blood-derived CD34 cell erythropoiesis. Exp. Hematol. 35, 551–564 (2007)

    Article  PubMed  CAS  Google Scholar 

  38. J. Chen, O. Odenike, J.D. Rowley, Leukaemogenesis: more than mutant genes. Nat. Rev. Cancer 10, 23–36 (2010)

    Article  PubMed  CAS  Google Scholar 

  39. G. Marcucci, M.D. Radmacher, K. Maharry, K. Mrozek, A.S. Ruppert, P. Paschka, T. Vukosavljevic, S.P. Whitman, C.D. Baldus, C. Langer, C.G. Liu, A.J. Carroll, B.L. Powell, R. Garzon, C.M. Croce, J.E. Kolitz, M.A. Caligiuri, R.A. Larson, C.D. Bloomfield, MicroRNA expression in cytogenetically normal acute myeloid leukemia. N. Engl. J. Med. 358, 1919–1928 (2008)

    Article  PubMed  CAS  Google Scholar 

  40. C. Thiede, S. Koch, E. Creutzig, C. Steudel, T. Illmer, M. Schaich, G. Ehninger, Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML). Blood 107, 4011–4020 (2006)

    Article  PubMed  CAS  Google Scholar 

  41. R. Garzon, M. Garofalo, M.P. Martelli, R. Briesewitz, L. Wang, C. Fernandez-Cymering, S. Volinia, C.G. Liu, S. Schnittger, T. Haferlach, A. Liso, D. Diverio, M. Mancini, G. Meloni, R. Foa, M.F. Martelli, C. Mecucci, C.M. Croce, B. Falini, Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc. Natl. Acad. Sci. U. S. A. 105, 3945–3950 (2008)

    Article  PubMed  CAS  Google Scholar 

  42. B. Falini, I. Nicoletti, M.F. Martelli, C. Mecucci, Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc + AML): biologic and clinical features. Blood 109, 874–885 (2007)

    Article  PubMed  CAS  Google Scholar 

  43. S. Yekta, I.H. Shih, D.P. Bartel, MicroRNA-directed cleavage of HOXB8 mRNA. Science 304, 594–596 (2004)

    Article  PubMed  CAS  Google Scholar 

  44. R.M. O'Connell, D.S. Rao, A.A. Chaudhuri, M.P. Boldin, K.D. Taganov, J. Nicoll, R.L. Paquette, D. Baltimore, Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. J Exp Med 205, 585–594 (2008)

    Article  PubMed  CAS  Google Scholar 

  45. R. Crazzolara, L. Bendall, Emerging treatments in acute lymphoblastic leukemia. Curr Cancer Drug Targets 9, 19–31 (2009)

    Article  PubMed  CAS  Google Scholar 

  46. S. Mi, J. Lu, M. Sun, Z. Li, H. Zhang, M.B. Neilly, Y. Wang, Z. Qian, J. Jin, Y. Zhang, S.K. Bohlander, M.M. Le Beau, R.A. Larson, T.R. Golub, J.D. Rowley, J. Chen, MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. Proc. Natl. Acad. Sci. U. S. A. 104, 19971–19976 (2007)

    Article  PubMed  CAS  Google Scholar 

  47. H. Zhang, X.Q. Luo, P. Zhang, L.B. Huang, Y.S. Zheng, J. Wu, H. Zhou, L.H. Qu, L. Xu, Y.Q. Chen, MicroRNA patterns associated with clinical prognostic parameters and CNS relapse prediction in pediatric acute leukemia. PLoS One 4, e7826 (2009)

    Article  PubMed  CAS  Google Scholar 

  48. D. Schotte, J.C. Chau, G. Sylvester, G. Liu, C. Chen, V.H. van der Velden, M.J. Broekhuis, T.C. Peters, R. Pieters, M.L. den Boer, Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia. Leukemia 23, 313–322 (2009)

    Article  PubMed  CAS  Google Scholar 

  49. D.L. Zanette, F. Rivadavia, G.A. Molfetta, F.G. Barbuzano, R. Proto-Siqueira, W.A. Silva-Jr, R.P. Falcao, M.A. Zago, miRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia. Braz J Med Biol Res 40, 1435–1440 (2007)

    Article  PubMed  CAS  Google Scholar 

  50. A. Ota, H. Tagawa, S. Karnan, S. Tsuzuki, A. Karpas, S. Kira, Y. Yoshida, M. Seto, Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res. 64, 3087–3095 (2004)

    Article  PubMed  CAS  Google Scholar 

  51. A. Ventura, A.G. Young, M.M. Winslow, L. Lintault, A. Meissner, S.J. Erkeland, J. Newman, R.T. Bronson, D. Crowley, J.R. Stone, R. Jaenisch, P.A. Sharp, T. Jacks, Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 132, 875–886 (2008)

    Article  PubMed  CAS  Google Scholar 

  52. L. He, J.M. Thomson, M.T. Hemann, E. Hernando-Monge, D. Mu, S. Goodson, S. Powers, C. Cordon-Cardo, S.W. Lowe, G.J. Hannon, S.M. Hammond, A microRNA polycistron as a potential human oncogene. Nature 435, 828–833 (2005)

    Article  PubMed  CAS  Google Scholar 

  53. M. Inomata, H. Tagawa, Y.M. Guo, Y. Kameoka, N. Takahashi, K. Sawada, MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes. Blood 113, 396–402 (2009)

    Article  PubMed  CAS  Google Scholar 

  54. L. O'Connor, A. Strasser, L.A. O'Reilly, G. Hausmann, J.M. Adams, S. Cory, D.C. Huang, Bim: a novel member of the Bcl-2 family that promotes apoptosis. EMBO J. 17, 384–395 (1998)

    Article  PubMed  Google Scholar 

  55. C. Dong, M. Ji, C. Ji, microRNAs and their potential target genes in leukemia pathogenesis. Cancer Biol Ther 8, 200–205 (2009)

    Article  PubMed  CAS  Google Scholar 

  56. C. Xiao, L. Srinivasan, D.P. Calado, H.C. Patterson, B. Zhang, J. Wang, J.M. Henderson, J.L. Kutok, K. Rajewsky, Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat. Immunol. 9, 405–414 (2008)

    Article  PubMed  CAS  Google Scholar 

  57. P. Mu, Y.C. Han, D. Betel, E. Yao, M. Squatrito, P. Ogrodowski, E. de Stanchina, A. D'Andrea, C. Sander, A. Ventura, Genetic dissection of the miR-17 92 cluster of microRNAs in Myc-induced B-cell lymphomas. Genes Dev. 23, 2806–2811 (2009)

    Article  PubMed  CAS  Google Scholar 

  58. V. Olive, M.J. Bennett, J.C. Walker, C. Ma, I. Jiang, C. Cordon-Cardo, Q.J. Li, S.W. Lowe, G.J. Hannon, L. He, miR-19 is a key oncogenic component of mir-17-92. Genes Dev. 23, 2839–2849 (2009)

    Article  PubMed  CAS  Google Scholar 

  59. C.L. Sawyers, Chronic myeloid leukemia. N. Engl. J. Med. 340, 1330–1340 (1999)

    Article  PubMed  CAS  Google Scholar 

  60. M.W. Deininger, J.M. Goldman, J.V. Melo, The molecular biology of chronic myeloid leukemia. Blood 96, 3343–3356 (2000)

    PubMed  CAS  Google Scholar 

  61. T.G. Lugo, A.M. Pendergast, A.J. Muller, O.N. Witte, Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. Science 247, 1079–1082 (1990)

    Article  PubMed  CAS  Google Scholar 

  62. Y.A. Mian, N.J. Zeleznik-Le, MicroRNAs in leukemias: emerging diagnostic tools and therapeutic targets. Curr Drug Targets 11, 801–811 (2010)

    Article  PubMed  CAS  Google Scholar 

  63. K. Woods, J.M. Thomson, S.M. Hammond, Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors. J. Biol. Chem. 282, 2130–2134 (2007)

    Article  PubMed  CAS  Google Scholar 

  64. K.A. O'Donnell, E.A. Wentzel, K.I. Zeller, C.V. Dang, J.T. Mendell, c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435, 839–843 (2005)

    Article  PubMed  CAS  Google Scholar 

  65. Y. Sylvestre, V. De Guire, E. Querido, U.K. Mukhopadhyay, V. Bourdeau, F. Major, G. Ferbeyre, P. Chartrand, An E2F/miR-20a autoregulatory feedback loop. J. Biol. Chem. 282, 2135–2143 (2007)

    Article  PubMed  CAS  Google Scholar 

  66. L. Venturini, K. Battmer, M. Castoldi, B. Schultheis, A. Hochhaus, M.U. Muckenthaler, A. Ganser, M. Eder, M. Scherr, Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells. Blood 109, 4399–4405 (2007)

    Article  PubMed  CAS  Google Scholar 

  67. M.J. Bueno, I. Perez de Castro, M. Gomez de Cedron, J. Santos, G.A. Calin, J.C. Cigudosa, C.M. Croce, J. Fernandez-Piqueras, M. Malumbres, Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell 13, 496–506 (2008)

    Article  PubMed  CAS  Google Scholar 

  68. X. Agirre, A. Jimenez-Velasco, E. San Jose-Eneriz, L. Garate, E. Bandres, L. Cordeu, O. Aparicio, B. Saez, G. Navarro, A. Vilas-Zornoza, I. Perez-Roger, J. Garcia-Foncillas, A. Torres, A. Heiniger, M.J. Calasanz, P. Fortes, J. Roman-Gomez, F. Prosper, Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth. Mol Cancer Res 6, 1830–1840 (2008)

    Article  PubMed  CAS  Google Scholar 

  69. S. Flamant, W. Ritchie, J. Guilhot, J. Holst, M.L. Bonnet, J.C. Chomel, F. Guilhot, A.G. Turhan, J.E. Rasko, Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemia. Haematologica 95, 1325–1333 (2010)

    Article  PubMed  CAS  Google Scholar 

  70. E. San Jose-Eneriz, J. Roman-Gomez, A. Jimenez-Velasco, L. Garate, V. Martin, L. Cordeu, A. Vilas-Zornoza, P. Rodriguez-Otero, M.J. Calasanz, F. Prosper, X. Agirre, MicroRNA expression profiling in Imatinib-resistant Chronic Myeloid Leukemia patients without clinically significant ABL1-mutations. Mol Cancer 8, 69 (2009)

    Article  PubMed  CAS  Google Scholar 

  71. G.A. Calin, M. Ferracin, A. Cimmino, G. Di Leva, M. Shimizu, S.E. Wojcik, M.V. Iorio, R. Visone, N.I. Sever, M. Fabbri, R. Iuliano, T. Palumbo, F. Pichiorri, C. Roldo, R. Garzon, C. Sevignani, L. Rassenti, H. Alder, S. Volinia, C.G. Liu, T.J. Kipps, M. Negrini, C.M. Croce, A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N. Engl. J. Med. 353, 1793–1801 (2005)

    Article  PubMed  CAS  Google Scholar 

  72. G.A. Calin, C.D. Dumitru, M. Shimizu, R. Bichi, S. Zupo, E. Noch, H. Aldler, S. Rattan, M. Keating, K. Rai, L. Rassenti, T. Kipps, M. Negrini, F. Bullrich, C.M. Croce, Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. U. S. A. 99, 15524–15529 (2002)

    Article  PubMed  CAS  Google Scholar 

  73. U. Klein, M. Lia, M. Crespo, R. Siegel, Q. Shen, T. Mo, A. Ambesi-Impiombato, A. Califano, A. Migliazza, G. Bhagat, R. Dalla-Favera, The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell 17, 28–40 (2010)

    Article  PubMed  CAS  Google Scholar 

  74. E.S. Raveche, E. Salerno, B.J. Scaglione, V. Manohar, F. Abbasi, Y.C. Lin, T. Fredrickson, P. Landgraf, S. Ramachandra, K. Huppi, J.R. Toro, V.E. Zenger, R.A. Metcalf, G.E. Marti, Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice. Blood 109, 5079–5086 (2007)

    Article  PubMed  CAS  Google Scholar 

  75. E. Salerno, B.J. Scaglione, F.D. Coffman, B.D. Brown, A. Baccarini, H. Fernandes, G. Marti, E.S. Raveche, Correcting miR-15a/16 genetic defect in New Zealand Black mouse model of CLL enhances drug sensitivity. Mol. Cancer Ther. 8, 2684–2692 (2009)

    Article  PubMed  CAS  Google Scholar 

  76. U. Klein, R. Dalla-Favera, New insights into the pathogenesis of chronic lymphocytic leukemia. Semin Cancer Biol 20, 377–383 (2010)

    Article  PubMed  CAS  Google Scholar 

  77. A. Cimmino, G.A. Calin, M. Fabbri, M.V. Iorio, M. Ferracin, M. Shimizu, S.E. Wojcik, R.I. Aqeilan, S. Zupo, M. Dono, L. Rassenti, H. Alder, S. Volinia, C.G. Liu, T.J. Kipps, M. Negrini, C.M. Croce, miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl. Acad. Sci. U. S. A. 102, 13944–13949 (2005)

    Article  PubMed  CAS  Google Scholar 

  78. G.A. Calin, A. Cimmino, M. Fabbri, M. Ferracin, S.E. Wojcik, M. Shimizu, C. Taccioli, N. Zanesi, R. Garzon, R.I. Aqeilan, H. Alder, S. Volinia, L. Rassenti, X. Liu, C.G. Liu, T.J. Kipps, M. Negrini, C.M. Croce, MiR-15a and miR-16-1 cluster functions in human leukemia. Proc. Natl. Acad. Sci. U. S. A. 105, 5166–5171 (2008)

    Article  PubMed  CAS  Google Scholar 

  79. R.W. Chen, L.T. Bemis, C.M. Amato, H. Myint, H. Tran, D.K. Birks, S.G. Eckhardt, W.A. Robinson, Truncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell lymphoma. Blood 112, 822–829 (2008)

    Article  PubMed  CAS  Google Scholar 

  80. P.S. Linsley, J. Schelter, J. Burchard, M. Kibukawa, M.M. Martin, S.R. Bartz, J.M. Johnson, J.M. Cummins, C.K. Raymond, H. Dai, N. Chau, M. Cleary, A.L. Jackson, M. Carleton, L. Lim, Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression. Mol. Cell. Biol. 27, 2240–2252 (2007)

    Article  PubMed  CAS  Google Scholar 

  81. P.S. Eis, W. Tam, L. Sun, A. Chadburn, Z. Li, M.F. Gomez, E. Lund, J.E. Dahlberg, Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc. Natl. Acad. Sci. U. S. A. 102, 3627–3632 (2005)

    Article  PubMed  CAS  Google Scholar 

  82. V. Fulci, S. Chiaretti, M. Goldoni, G. Azzalin, N. Carucci, S. Tavolaro, L. Castellano, A. Magrelli, F. Citarella, M. Messina, R. Maggio, N. Peragine, S. Santangelo, F.R. Mauro, P. Landgraf, T. Tuschl, D.B. Weir, M. Chien, J.J. Russo, J. Ju, R. Sheridan, C. Sander, M. Zavolan, A. Guarini, R. Foa, G. Macino, Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. Blood 109, 4944–4951 (2007)

    Article  PubMed  CAS  Google Scholar 

  83. S. Costinean, N. Zanesi, Y. Pekarsky, E. Tili, S. Volinia, N. Heerema, C.M. Croce, Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 103, 7024–7029 (2006)

    Article  PubMed  CAS  Google Scholar 

  84. C.H. Lawrie, S. Soneji, T. Marafioti, C.D. Cooper, S. Palazzo, J.C. Paterson, H. Cattan, T. Enver, R. Mager, J. Boultwood, J.S. Wainscoat, C.S. Hatton, MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. Int. J. Cancer 121, 1156–1161 (2007)

    Article  PubMed  CAS  Google Scholar 

  85. T.H. Thai, D.P. Calado, S. Casola, K.M. Ansel, C. Xiao, Y. Xue, A. Murphy, D. Frendewey, D. Valenzuela, J.L. Kutok, M. Schmidt-Supprian, N. Rajewsky, G. Yancopoulos, A. Rao, K. Rajewsky, Regulation of the germinal center response by microRNA-155. Science 316, 604–608 (2007)

    Article  PubMed  CAS  Google Scholar 

  86. B.J. Scaglione, E. Salerno, M. Balan, F. Coffman, P. Landgraf, F. Abbasi, S. Kotenko, G.E. Marti, E.S. Raveche, Murine models of chronic lymphocytic leukaemia: role of microRNA-16 in the New Zealand Black mouse model. Br. J. Haematol. 139, 645–657 (2007)

    Article  PubMed  CAS  Google Scholar 

  87. A. Rodriguez, E. Vigorito, S. Clare, M.V. Warren, P. Couttet, D.R. Soond, S. van Dongen, R.J. Grocock, P.P. Das, E.A. Miska, D. Vetrie, K. Okkenhaug, A.J. Enright, G. Dougan, M. Turner, A. Bradley, Requirement of bic/microRNA-155 for normal immune function. Science 316, 608–611 (2007)

    Article  PubMed  CAS  Google Scholar 

  88. G.T. Bommer, I. Gerin, Y. Feng, A.J. Kaczorowski, R. Kuick, R.E. Love, Y. Zhai, T.J. Giordano, Z.S. Qin, B.B. Moore, O.A. MacDougald, K.R. Cho, E.R. Fearon, p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr. Biol. 17, 1298–1307 (2007)

    Article  PubMed  CAS  Google Scholar 

  89. T.C. Chang, E.A. Wentzel, O.A. Kent, K. Ramachandran, M. Mullendore, K.H. Lee, G. Feldmann, M. Yamakuchi, M. Ferlito, C.J. Lowenstein, D.E. Arking, M.A. Beer, A. Maitra, J.T. Mendell, Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 26, 745–752 (2007)

    Article  PubMed  CAS  Google Scholar 

  90. L. He, X. He, L.P. Lim, E. de Stanchina, Z. Xuan, Y. Liang, W. Xue, L. Zender, J. Magnus, D. Ridzon, A.L. Jackson, P.S. Linsley, C. Chen, S.W. Lowe, M.A. Cleary, G.J. Hannon, A microRNA component of the p53 tumour suppressor network. Nature 447, 1130–1134 (2007)

    Article  PubMed  CAS  Google Scholar 

  91. X. He, L. He, G.J. Hannon, The guardian's little helper: microRNAs in the p53 tumor suppressor network. Cancer Res. 67, 11099–11101 (2007)

    Article  PubMed  CAS  Google Scholar 

  92. L. He, X. He, S.W. Lowe, G.J. Hannon, microRNAs join the p53 network–another piece in the tumour-suppression puzzle. Nat. Rev. Cancer 7, 819–822 (2007)

    Article  PubMed  CAS  Google Scholar 

  93. J.S. Wei, Y.K. Song, S. Durinck, Q.R. Chen, A.T. Cheuk, P. Tsang, Q. Zhang, C.J. Thiele, A. Slack, J. Shohet, J. Khan, The MYCN oncogene is a direct target of miR-34a. Oncogene 27, 5204–5213 (2008)

    Article  PubMed  CAS  Google Scholar 

  94. C. Welch, Y. Chen, R.L. Stallings, MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene 26, 5017–5022 (2007)

    Article  PubMed  CAS  Google Scholar 

  95. D. Asslaber, J.D. Pinon, I. Seyfried, P. Desch, M. Stocher, I. Tinhofer, A. Egle, O. Merkel, R. Greil, microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia. Blood 115, 4191–4197 (2010)

    Article  PubMed  CAS  Google Scholar 

  96. M. Yamakuchi, M. Ferlito, C.J. Lowenstein, miR-34a repression of SIRT1 regulates apoptosis. Proc. Natl. Acad. Sci. U. S. A. 105, 13421–13426 (2008)

    Article  PubMed  CAS  Google Scholar 

  97. M.K. Dijkstra, K. van Lom, D. Tielemans, F. Elstrodt, A.W. Langerak, M.B. van 't Veer, M. Jongen-Lavrencic, 17p13/TP53 deletion in B-CLL patients is associated with microRNA-34a downregulation. Leukemia 23, 625–627 (2009)

    Article  PubMed  CAS  Google Scholar 

  98. T. Zenz, J. Mohr, E. Eldering, A.P. Kater, A. Buhler, D. Kienle, D. Winkler, J. Durig, M.H. van Oers, D. Mertens, H. Dohner, S. Stilgenbauer, miR-34a as part of the resistance network in chronic lymphocytic leukemia. Blood 113, 3801–3808 (2009)

    Article  PubMed  CAS  Google Scholar 

  99. Y. Pekarsky, U. Santanam, A. Cimmino, A. Palamarchuk, A. Efanov, V. Maximov, S. Volinia, H. Alder, C.G. Liu, L. Rassenti, G.A. Calin, J.P. Hagan, T. Kipps, C.M. Croce, Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res. 66, 11590–11593 (2006)

    Article  PubMed  CAS  Google Scholar 

  100. M.S. Nicoloso, T.J. Kipps, C.M. Croce, G.A. Calin, MicroRNAs in the pathogeny of chronic lymphocytic leukaemia. Br. J. Haematol. 139, 709–716 (2007)

    Article  PubMed  CAS  Google Scholar 

  101. R. Bichi, S.A. Shinton, E.S. Martin, A. Koval, G.A. Calin, R. Cesari, G. Russo, R.R. Hardy, C.M. Croce, Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression. Proc. Natl. Acad. Sci. U. S. A. 99, 6955–6960 (2002)

    Article  PubMed  CAS  Google Scholar 

  102. X.J. Yan, E. Albesiano, N. Zanesi, S. Yancopoulos, A. Sawyer, E. Romano, A. Petlickovski, D.G. Efremov, C.M. Croce, N. Chiorazzi, B cell receptors in TCL1 transgenic mice resemble those of aggressive, treatment-resistant human chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. U. S. A. 103, 11713–11718 (2006)

    Article  PubMed  CAS  Google Scholar 

  103. S. Marton, M.R. Garcia, C. Robello, H. Persson, F. Trajtenberg, O. Pritsch, C. Rovira, H. Naya, G. Dighiero, A. Cayota, Small RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesis. Leukemia 22, 330–338 (2008)

    Article  PubMed  CAS  Google Scholar 

  104. B. Stamatopoulos, N. Meuleman, B. Haibe-Kains, P. Saussoy, E. Van Den Neste, L. Michaux, P. Heimann, P. Martiat, D. Bron, L. Lagneaux, microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification. Blood 113, 5237–5245 (2009)

    Article  PubMed  CAS  Google Scholar 

  105. W.C. Cho, MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int. J. Biochem. Cell Biol. 42, 1273–1281 (2010)

    Article  PubMed  CAS  Google Scholar 

  106. S. Rossi, M. Shimizu, E. Barbarotto, M.S. Nicoloso, F. Dimitri, D. Sampath, M. Fabbri, S. Lerner, L.L. Barron, L.Z. Rassenti, L. Jiang, L. Xiao, J. Hu, P. Secchiero, G. Zauli, S. Volinia, M. Negrini, W. Wierda, T.J. Kipps, W. Plunkett, K.R. Coombes, L.V. Abruzzo, M.J. Keating, G.A. Calin, microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival. Blood 116, 945–952 (2010)

    Article  PubMed  CAS  Google Scholar 

  107. S. Gilad, E. Meiri, Y. Yogev, S. Benjamin, D. Lebanony, N. Yerushalmi, H. Benjamin, M. Kushnir, H. Cholakh, N. Melamed, Z. Bentwich, M. Hod, Y. Goren, A. Chajut, Serum microRNAs are promising novel biomarkers. PLoS One 3, e3148 (2008)

    Article  PubMed  CAS  Google Scholar 

  108. P.S. Mitchell, R.K. Parkin, E.M. Kroh, B.R. Fritz, S.K. Wyman, E.L. Pogosova-Agadjanyan, A. Peterson, J. Noteboom, K.C. O'Briant, A. Allen, D.W. Lin, N. Urban, C.W. Drescher, B.S. Knudsen, D.L. Stirewalt, R. Gentleman, R.L. Vessella, P.S. Nelson, D.B. Martin, M. Tewari, Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. U. S. A. 105, 10513–10518 (2008)

    Article  PubMed  CAS  Google Scholar 

  109. M. Tanaka, K. Oikawa, M. Takanashi, M. Kudo, J. Ohyashiki, K. Ohyashiki, M. Kuroda, Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients. PLoS One 4, e5532 (2009)

    Article  PubMed  CAS  Google Scholar 

  110. R. Hummel, D.J. Hussey, J. Haier, MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types. Eur. J. Cancer 46, 298–311 (2010)

    Article  PubMed  CAS  Google Scholar 

  111. E. Moussay, V. Palissot, L. Vallar, H.A. Poirel, T. Wenner, V. El Khoury, N. Aouali, K. Van Moer, B. Leners, F. Bernardin, A. Muller, P. Cornillet-Lefebvre, A. Delmer, C. Duhem, F. Ries, E. van Dyck, G. Berchem, Determination of genes and microRNAs involved in the resistance to fludarabine in vivo in chronic lymphocytic leukemia. Mol Cancer 9, 115 (2010)

    Article  PubMed  CAS  Google Scholar 

  112. F. Meng, R. Henson, M. Lang, H. Wehbe, S. Maheshwari, J.T. Mendell, J. Jiang, T.D. Schmittgen, T. Patel, Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 130, 2113–2129 (2006)

    Article  PubMed  CAS  Google Scholar 

  113. J. Krutzfeldt, N. Rajewsky, R. Braich, K.G. Rajeev, T. Tuschl, M. Manoharan, M. Stoffel, Silencing of microRNAs in vivo with 'antagomirs'. Nature 438, 685–689 (2005)

    Article  PubMed  CAS  Google Scholar 

  114. U.A. Orom, S. Kauppinen, A.H. Lund, LNA-modified oligonucleotides mediate specific inhibition of microRNA function. Gene 372, 137–141 (2006)

    Article  PubMed  CAS  Google Scholar 

  115. K.J. Mavrakis, A.L. Wolfe, E. Oricchio, T. Palomero, K. de Keersmaecker, K. McJunkin, J. Zuber, T. James, A.A. Khan, C.S. Leslie, J.S. Parker, P.J. Paddison, W. Tam, A. Ferrando, H.G. Wendel, Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia. Nat Cell Biol 12, 372–379 (2010)

    Article  PubMed  CAS  Google Scholar 

  116. D. Schotte, R. Pieters, M.L. Den Boer, MicroRNAs in acute leukemia: from biological players to clinical contributors. Leukemia 26, 1–12 (2012)

    Article  PubMed  CAS  Google Scholar 

  117. J. Krutzfeldt, S. Kuwajima, R. Braich, K.G. Rajeev, J. Pena, T. Tuschl, M. Manoharan, M. Stoffel, Specificity, duplex degradation and subcellular localization of antagomirs. Nucleic Acids Res. 35, 2885–2892 (2007)

    Article  PubMed  CAS  Google Scholar 

  118. J. Elmen, M. Lindow, A. Silahtaroglu, M. Bak, M. Christensen, A. Lind-Thomsen, M. Hedtjarn, J.B. Hansen, H.F. Hansen, E.M. Straarup, K. McCullagh, P. Kearney, S. Kauppinen, Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res. 36, 1153–1162 (2008)

    Article  PubMed  CAS  Google Scholar 

  119. J. Elmen, M. Lindow, S. Schutz, M. Lawrence, A. Petri, S. Obad, M. Lindholm, M. Hedtjarn, H.F. Hansen, U. Berger, S. Gullans, P. Kearney, P. Sarnow, E.M. Straarup, S. Kauppinen, LNA-mediated microRNA silencing in non-human primates. Nature 452, 896–899 (2008)

    Article  PubMed  CAS  Google Scholar 

  120. A.W. Tong, J. Nemunaitis, Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy? Cancer Gene Ther 15, 341–355 (2008)

    Article  PubMed  CAS  Google Scholar 

  121. W. Wu, M. Sun, G.M. Zou, J. Chen, MicroRNA and cancer: Current status and prospective. Int. J. Cancer 120, 953–960 (2007)

    Article  PubMed  CAS  Google Scholar 

  122. Y. Hayashita, H. Osada, Y. Tatematsu, H. Yamada, K. Yanagisawa, S. Tomida, Y. Yatabe, K. Kawahara, Y. Sekido, T. Takahashi, A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res. 65, 9628–9632 (2005)

    Article  PubMed  CAS  Google Scholar 

  123. S. Volinia, G.A. Calin, C.G. Liu, S. Ambs, A. Cimmino, F. Petrocca, R. Visone, M. Iorio, C. Roldo, M. Ferracin, R.L. Prueitt, N. Yanaihara, G. Lanza, A. Scarpa, A. Vecchione, M. Negrini, C.C. Harris, C.M. Croce, A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. U. S. A. 103, 2257–2261 (2006)

    Article  PubMed  CAS  Google Scholar 

  124. G.A. Calin, C.G. Liu, C. Sevignani, M. Ferracin, N. Felli, C.D. Dumitru, M. Shimizu, A. Cimmino, S. Zupo, M. Dono, M.L. Dell'Aquila, H. Alder, L. Rassenti, T.J. Kipps, F. Bullrich, M. Negrini, C.M. Croce, MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc. Natl. Acad. Sci. U. S. A. 101, 11755–11760 (2004)

    Article  PubMed  CAS  Google Scholar 

  125. Z. Yu, C. Wang, M. Wang, Z. Li, M.C. Casimiro, M. Liu, K. Wu, J. Whittle, X. Ju, T. Hyslop, P. McCue, R.G. Pestell, A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation. J Cell Biol 182, 509–517 (2008)

    Article  PubMed  CAS  Google Scholar 

  126. H. Becker, G. Marcucci, K. Maharry, M.D. Radmacher, K. Mrozek, D. Margeson, S.P. Whitman, Y.Z. Wu, S. Schwind, P. Paschka, B.L. Powell, T.H. Carter, J.E. Kolitz, M. Wetzler, A.J. Carroll, M.R. Baer, M.A. Caligiuri, R.A. Larson, C.D. Bloomfield, Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study. J. Clin. Oncol. 28, 596–604 (2010)

    Article  PubMed  CAS  Google Scholar 

  127. Y. Pekarsky, A. Koval, C. Hallas, R. Bichi, M. Tresini, S. Malstrom, G. Russo, P. Tsichlis, C.M. Croce, Tcl1 enhances Akt kinase activity and mediates its nuclear translocation. Proc. Natl. Acad. Sci. U. S. A. 97, 3028–3033 (2000)

    Article  PubMed  CAS  Google Scholar 

  128. R. Garzon, F. Pichiorri, T. Palumbo, M. Visentini, R. Aqeilan, A. Cimmino, H. Wang, H. Sun, S. Volinia, H. Alder, G.A. Calin, C.G. Liu, M. Andreeff, C.M. Croce, MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. Oncogene 26, 4148–4157 (2007)

    Article  PubMed  CAS  Google Scholar 

  129. D. Sampath, G.A. Calin, V.K. Puduvalli, G. Gopisetty, C. Taccioli, C.G. Liu, B. Ewald, C. Liu, M.J. Keating, W. Plunkett, Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradation. Blood 113, 3744–3753 (2009)

    Article  PubMed  CAS  Google Scholar 

  130. F. Isken, B. Steffen, S. Merk, M. Dugas, B. Markus, N. Tidow, M. Zuhlsdorf, T. Illmer, C. Thiede, W.E. Berdel, H. Serve, C. Muller-Tidow, Identification of acute myeloid leukaemia associated microRNA expression patterns. Br. J. Haematol. 140, 153–161 (2008)

    Article  PubMed  CAS  Google Scholar 

  131. C. Langer, M.D. Radmacher, A.S. Ruppert, S.P. Whitman, P. Paschka, K. Mrozek, C.D. Baldus, T. Vukosavljevic, C.G. Liu, M.E. Ross, B.L. Powell, A. de la Chapelle, J.E. Kolitz, R.A. Larson, G. Marcucci, C.D. Bloomfield, High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) study. Blood 111, 5371–5379 (2008)

    Article  PubMed  CAS  Google Scholar 

  132. C. Xiao, D.P. Calado, G. Galler, T.H. Thai, H.C. Patterson, J. Wang, N. Rajewsky, T.P. Bender, K. Rajewsky, MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 131, 146–159 (2007)

    Article  PubMed  CAS  Google Scholar 

  133. K. Machova Polakova, T. Lopotova, H. Klamova, P. Burda, M. Trneny, T. Stopka, J. Moravcova, Expression patterns of microRNAs associated with CML phases and their disease related targets. Mol Cancer 10, 41 (2011)

    Article  PubMed  CAS  Google Scholar 

  134. R. Garzon, F. Pichiorri, T. Palumbo, R. Iuliano, A. Cimmino, R. Aqeilan, S. Volinia, D. Bhatt, H. Alder, G. Marcucci, G.A. Calin, C.G. Liu, C.D. Bloomfield, M. Andreeff, C.M. Croce, MicroRNA fingerprints during human megakaryocytopoiesis. Proc. Natl. Acad. Sci. U. S. A. 103, 5078–5083 (2006)

    Article  PubMed  CAS  Google Scholar 

  135. H. Bruchova, D. Yoon, A.M. Agarwal, J. Mendell, J.T. Prchal, Regulated expression of microRNAs in normal and polycythemia vera erythropoiesis. Exp. Hematol. 35, 1657–1667 (2007)

    Article  PubMed  CAS  Google Scholar 

  136. R.W. Georgantas 3rd, R. Hildreth, S. Morisot, J. Alder, C.G. Liu, S. Heimfeld, G.A. Calin, C.M. Croce, C.I. Civin, CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc. Natl. Acad. Sci. U. S. A. 104, 2750–2755 (2007)

    Article  PubMed  CAS  Google Scholar 

  137. G. Marcucci, K. Mrozek, M.D. Radmacher, R. Garzon, C.D. Bloomfield, The prognostic and functional role of microRNAs in acute myeloid leukemia. Blood 117, 1121–1129 (2011)

    Article  PubMed  CAS  Google Scholar 

  138. S. Debernardi, S. Skoulakis, G. Molloy, T. Chaplin, A. Dixon-McIver, B.D. Young, MicroRNA miR-181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysis. Leukemia 21, 912–916 (2007)

    PubMed  CAS  Google Scholar 

  139. U. Thorsteinsdottir, A. Mamo, E. Kroon, L. Jerome, J. Bijl, H.J. Lawrence, K. Humphries, G. Sauvageau, Overexpression of the myeloid leukemia-associated Hoxa9 gene in bone marrow cells induces stem cell expansion. Blood 99, 121–129 (2002)

    Article  PubMed  CAS  Google Scholar 

  140. N. Felli, L. Fontana, E. Pelosi, R. Botta, D. Bonci, F. Facchiano, F. Liuzzi, V. Lulli, O. Morsilli, S. Santoro, M. Valtieri, G.A. Calin, C.G. Liu, A. Sorrentino, C.M. Croce, C. Peschle, MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc. Natl. Acad. Sci. U. S. A. 102, 18081–18086 (2005)

    Article  PubMed  CAS  Google Scholar 

  141. S.M. Tanner, J.L. Austin, G. Leone, L.J. Rush, C. Plass, K. Heinonen, K. Mrozek, H. Sill, S. Knuutila, J.E. Kolitz, K.J. Archer, M.A. Caligiuri, C.D. Bloomfield, A. de La Chapelle, BAALC, the human member of a novel mammalian neuroectoderm gene lineage, is implicated in hematopoiesis and acute leukemia. Proc. Natl. Acad. Sci. U. S. A. 98, 13901–13906 (2001)

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The authors wish to thank David Leif Anderson for valuable comments on the manuscript. This work was supported by a grant from Tarbiat Modares University.

Conflicts of interest

The authors declare that there are no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Sadegh Babashah or Masoud Soleimani.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Babashah, S., Sadeghizadeh, M., Tavirani, M.R. et al. Aberrant microRNA expression and its implications in the pathogenesis of leukemias. Cell Oncol. 35, 317–334 (2012). https://doi.org/10.1007/s13402-012-0095-3

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13402-012-0095-3

Keywords

Navigation